Northern Trust Corp Pliant Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 502,016 shares of PLRX stock, worth $6.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

502,016

Previous 477,165 5.21%

Holding current value

$6.18 Million

Previous $5.13 Million 9.71%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.52 - $14.35 $261,432 - $356,611	24,851 Added 5.21%	502,016 $5.63 Million
Q2 2024 Aug 14, 2024	SELL	$10.58 - $15.61 $191,751 - $282,915	-18,124 Reduced 3.66%	477,165 $5.13 Million
Q1 2024 May 14, 2024	SELL	$14.14 - $19.59 $141,923 - $196,624	-10,037 Reduced 1.99%	495,289 $7.38 Million
Q4 2023 Feb 13, 2024	BUY	$12.85 - $19.15 $4,754 - $7,085	370 Added 0.07%	505,326 $9.15 Million
Q3 2023 Nov 13, 2023	BUY	$14.58 - $20.15 $206,525 - $285,424	14,165 Added 2.89%	504,956 $8.76 Million
Q2 2023 Aug 11, 2023	BUY	$18.12 - $30.56 $7.01 Million - $11.8 Million	387,124 Added 373.43%	490,791 $8.89 Million
Q1 2023 May 15, 2023	BUY	$18.73 - $36.26 $417,585 - $808,416	22,295 Added 27.4%	103,667 $2.76 Million
Q4 2022 Feb 13, 2023	BUY	$17.0 - $25.43 $426,207 - $637,555	25,071 Added 44.53%	81,372 $1.57 Million
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $142,201 - $449,224	18,540 Added 49.1%	56,301 $1.18 Million
Q2 2022 Aug 12, 2022	SELL	$4.11 - $8.75 $722,981 - $1.54 Million	-175,908 Reduced 82.33%	37,761 $302,000
Q1 2022 May 13, 2022	SELL	$7.01 - $14.1 $103,621 - $208,426	-14,782 Reduced 6.47%	213,669 $1.5 Million
Q4 2021 Feb 08, 2022	BUY	$12.27 - $18.26 $44,552 - $66,302	3,631 Added 1.62%	228,451 $3.08 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $143,343 - $252,068	8,698 Added 4.02%	224,820 $3.8 Million
Q2 2021 Aug 13, 2021	SELL	$28.05 - $37.69 $167,458 - $225,009	-5,970 Reduced 2.69%	216,122 $6.29 Million
Q1 2021 May 12, 2021	BUY	$24.52 - $40.23 $2.47 Million - $4.05 Million	100,556 Added 82.74%	222,092 $8.74 Million
Q4 2020 Feb 11, 2021	BUY	$19.89 - $32.99 $6,404 - $10,622	322 Added 0.27%	121,536 $2.76 Million
Q3 2020 Nov 16, 2020	BUY	$21.54 - $29.53 $2.61 Million - $3.58 Million	121,214 New	121,214 $2.75 Million

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Pliant Therapeutics, Inc. Transaction History